RDH13-NLRP9 Fusion FISH Probe
The RDH13-NLRP9 Fusion FISH Probe is used to confirm a fusion of the RDH13 and NLRP9 genes. The fusion of the RDH13 and NLRP9 genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| RDH13-NLRP9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| RDH13-NLRP9-20-AQAQ | 20 (40 μL) | 200 μL |
|
RDH13 Gene Summary
This gene encodes a mitochondrial short-chain dehydrogenase/reductase, which catalyzes the reduction and oxidation of retinoids. The encoded enzyme may function in retinoic acid production and may also protect the mitochondria against oxidative stress. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]
Gene Name: Retinol Dehydrogenase 13
Chromosome: CHR19: 55555691 -55580914
Locus: 19q13.42
NLRP9 Gene Summary
The protein encoded by this gene belongs to the NALP protein family. Members of the NALP protein family typically contain a NACHT domain, a NACHT-associated domain (NAD), a C-terminal leucine-rich repeat (LRR) region, and an N-terminal pyrin domain (PYD). This protein may play a regulatory role in the innate immune system as similar family members belong to the signal-induced multiprotein complex, the inflammasome, that activates the pro-inflammatory caspases, caspase-1 and caspase-5. [provided by RefSeq, Jul 2008]
Gene Name: NLR Family Pyrin Domain Containing 9
Chromosome: CHR19: 56219797 -56249768
Locus: 19q13.42
Gene Diseases
The RDH13 NLRP9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|